Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Biomarker-guided Assessment of Neurocognitive Impairment in Patients With COVID-19 - a Multicenter Case-control Study

NCT04359914 is registered in ClinicalTrials.gov with University of Rostock as lead sponsor.

NCT NCT04359914
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04359914 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Biomarker-guided Assessment of Neurocognitive Impairment in Patients With COVID-19 - a Multicenter Case-control Study
Lead sponsor
University of Rostock
Phase
Observational
Overall status
Completed
Start date
April 15, 2020
Completion date
December 31, 2023
Enrollment
118 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

central nervous system injury, covid-19, critical illness, delirium, encephalopathy